De Marchis M L, Ballarino M, Salvatori B, Puzzolo M C, Bozzoni I, Fatica A
Department of Genetics and Molecular Biology, Institute Pasteur Cenci-Bolognetti, Sapienza University, Rome, Italy.
Leukemia. 2009 May;23(5):856-62. doi: 10.1038/leu.2008.372. Epub 2009 Jan 8.
In the acute promyelocytic leukemia (APL) bearing the t(15;17), all-trans-retinoic acid (ATRA) treatment induces granulocytic maturation and complete remission of leukemia. We identified miR-342 as one of the microRNAs (miRNAs) upregulated by ATRA during APL differentiation. This miRNA emerged as a direct transcriptional target of the critical hematopoietic transcription factors PU.1 and interferon regulatory factor (IRF)-1 and IRF-9. IRF-1 maintains miR-342 at low levels, whereas the binding of PU.1 and IRF-9 in the promoter region following retinoic ATRA-mediated differentiation, upregulates miR-342 expression. Moreover, we showed that enforced expression of miR-342 in APL cells stimulated ATRA-induced differentiation. These data identified miR-342 as a new player in the granulocytic differentiation program activated by ATRA in APL.
在携带t(15;17)的急性早幼粒细胞白血病(APL)中,全反式维甲酸(ATRA)治疗可诱导粒细胞成熟并使白血病完全缓解。我们鉴定出miR-342是APL分化过程中受ATRA上调的微小RNA(miRNA)之一。该miRNA是关键造血转录因子PU.1和干扰素调节因子(IRF)-1及IRF-9的直接转录靶点。IRF-1使miR-342维持在低水平,而在维甲酸介导的分化后,PU.1和IRF-9在启动子区域的结合会上调miR-342的表达。此外,我们发现APL细胞中miR-342的强制表达可刺激ATRA诱导的分化。这些数据表明miR-342是APL中由ATRA激活的粒细胞分化程序中的一个新参与者。